Insider · CIK 0001341011

North Annette

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001341011

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-02-09	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−669 sh	$36.30	−$24.3K	11,696
2022-02-09	Turning Point Therapeutics, Inc.A Award	EVP & General Counsel	AAward	+16.3K sh	—	—	27,979
2022-02-09	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	EVP & General Counsel	AAward	+58.6K sh	—	—	58,600
2021-08-30	Turning Point Therapeutics, Inc.M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	+10K sh	$17.00	+$170K	22,365
2021-08-30	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−10K sh	$80.00	−$800K	12,365
2021-08-30	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	−10K sh	—	—	144,609
2021-06-15	Turning Point Therapeutics, Inc.M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	+15K sh	$17.00	+$255K	27,365
2021-06-15	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−5,666 sh	$75.94	−$430K	21,699
2021-06-15	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−2,700 sh	$77.37	−$209K	18,999
2021-06-15	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−6,634 sh	$77.82	−$516K	12,365
2021-06-15	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	−15K sh	—	—	154,609
2021-05-06	Turning Point Therapeutics, Inc.M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	+5,882 sh	$17.00	+$100K	12,365
2021-05-06	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	−5,882 sh	—	—	169,609
2021-03-08	Turning Point Therapeutics, Inc.M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	+20K sh	$17.00	+$340K	26,483
2021-03-08	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−500 sh	$103.30	−$51.7K	25,983
2021-03-08	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−4,810 sh	$109.09	−$525K	21,173
2021-03-08	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−9,419 sh	$109.89	−$1.04M	11,754
2021-03-08	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−4,571 sh	$110.77	−$506K	7,183
2021-03-08	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−700 sh	$111.69	−$78.2K	6,483
2021-03-08	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	−20K sh	—	—	175,491
2021-02-08	Turning Point Therapeutics, Inc.A Award	EVP & General Counsel	AAward	+6,483 sh	—	—	6,483
2021-02-08	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	EVP & General Counsel	AAward	+29.2K sh	—	—	29,175
2021-02-02	Turning Point Therapeutics, Inc.M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	+9,016 sh	$17.00	+$153K	9,016
2021-02-02	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−400 sh	$126.66	−$50.7K	8,616
2021-02-02	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−900 sh	$127.83	−$115K	7,716
2021-02-02	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−500 sh	$128.74	−$64.4K	7,216
2021-02-02	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−2,860 sh	$129.75	−$371K	4,356
2021-02-02	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−3,752 sh	$130.64	−$490K	604
2021-02-02	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−604 sh	$131.89	−$79.7K	0
2021-02-02	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	−9,016 sh	—	—	195,491
2021-02-01	Turning Point Therapeutics, Inc.M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	+16K sh	$17.00	+$272K	15,984
2021-02-01	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−1,630 sh	$122.58	−$200K	14,354
2021-02-01	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−10.5K sh	$123.49	−$1.3M	3,813
2021-02-01	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−3,313 sh	$124.41	−$412K	500
2021-02-01	Turning Point Therapeutics, Inc.S Sale	EVP & General Counsel	SSale	−500 sh	$125.38	−$62.7K	0
2021-02-01	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	EVP & General Counsel	MExercise/Conversion	−16K sh	—	—	204,507
2020-01-06	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	EVP & General Counsel	AAward	+56K sh	—	—	56,000
2019-01-22	KURAKura Oncology, Inc. · Option to purchase common stockA Award	SVP, General Counsel	AAward	+100K sh	—	—	100,000
2018-01-24	KURAKura Oncology, Inc. · Option to purchase common stockA Award	SVP, General Counsel	AAward	+70K sh	—	—	70,000
2017-01-23	KURAKura Oncology, Inc. · Option to purchase common stockA Award	SVP, General Counsel	AAward	+72K sh	—	—	72,000
2016-01-29	KURAKura Oncology, Inc. · Option to purchase common stockA Award	SVP, General Counsel	AAward	+80K sh	—	—	80,000
2015-04-23	KURAKura Oncology, Inc. · Option to purchase common stockA Award	SVP, General Counsel	AAward	+81.3K sh	—	—	81,250
2014-11-10	AMBIT BIOSCIENCES CORPStock Option (Right to Buy)D Disposition to Issuer	Senior VP and General Counsel	DDisposition to Issuer	−66K sh	$3.19	−$211K	0
2014-11-10	AMBIT BIOSCIENCES CORPStock Option (Right to Buy)D Disposition to Issuer	Senior VP and General Counsel	DDisposition to Issuer	−40K sh	$4.20	−$168K	0
2014-11-10	AMBIT BIOSCIENCES CORPRestricted Stock UnitsD Disposition to Issuer	Senior VP and General Counsel	DDisposition to Issuer	−63.5K sh	$15.00	−$953K	0
2014-01-08	AMBIT BIOSCIENCES CORPStock Option (Right to Buy)A Award	Senior VP and General Counsel	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Feb 114
North Annette0001209191-22-008981
SEC(opens sec.gov)
Aug 314
North Annette0001209191-21-054117
SEC(opens sec.gov)
Jun 164
North Annette0001209191-21-040984
SEC(opens sec.gov)
May 74
North Annette0001209191-21-030925
SEC(opens sec.gov)
Mar 94
North Annette0001209191-21-019268
SEC(opens sec.gov)

Companies

Address

C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET

SAN DIEGO, CA, 92121